Literature DB >> 10471296

Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.

S W Kim1, T L Ortel, M A Quinn-Allen, L Yoo, L Worfolk, X Zhai, B R Lentz, W H Kane.   

Abstract

Thrombin-activated factor Va exists as two isoforms, factor Va(1) and factor Va(2), which differ in the size of their light chains and their affinity for biological membranes. The heterogeneity of the light chain remained following incubation of factor Va with N-glycanase. However, we found that the factor V C2 domain, which contains a single potential glycosylation site at Asn-2181, was partially glycosylated when expressed in COS cells. To confirm the structural basis for factor Va(1) and factor Va(2), we mutated Asn-2181 to glutamine (N2181Q) and expressed this mutant using a B domain deletion construct (rHFV des B) in COS cells. Thrombin activation of N2181Q released a light chain with mobility identical to that of factor Va(2) on SDS-PAGE. The functional properties of purified N2181Q were similar to those of factor Va(2) in prothrombinase assays carried out in the presence of limiting concentrations of phosphatidylserine. The binding of human factor Va(1) and factor Va(2) to 75:25 POPC/POPS vesicles was also investigated in equilibrium binding assays using proteins containing a fluorescein-labeled heavy chain. The affinity of human factor Va(2) binding to POPC/POPS vesicles was approximately 3-fold higher than that of factor Va(1). These results indicate that partial glycosylation of factor V at asparagine-2181 is the structural basis of the light chain doublet and that the presence of this oligosaccharide reduces the affinity of factor Va for biological membranes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471296     DOI: 10.1021/bi991275y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Novel role for galectin-8 protein as mediator of coagulation factor V endocytosis by megakaryocytes.

Authors:  Claudia Zappelli; Carmen van der Zwaan; Daphne C Thijssen-Timmer; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

2.  Factor VIII C1 domain spikes 2092-2093 and 2158-2159 comprise regions that modulate cofactor function and cellular uptake.

Authors:  Esther Bloem; Maartje van den Biggelaar; Aleksandra Wroblewska; Jan Voorberg; Johan H Faber; Marianne Kjalke; Henning R Stennicke; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2013-09-05       Impact factor: 5.157

3.  Phosphatidylserine and FVa regulate FXa structure.

Authors:  Kinshuk Raj Srivasatava; Rinku Majumder; William H Kane; Mary Ann Quinn-Allen; Barry R Lentz
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

4.  A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.

Authors:  Rinku Majumder; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  Blood       Date:  2008-06-27       Impact factor: 22.113

5.  Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.

Authors:  Rinku Majumder; Tilen Koklic; Alireza R Rezaie; Barry R Lentz
Journal:  Biochemistry       Date:  2012-12-27       Impact factor: 3.162

Review 6.  Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding.

Authors:  Mark Schreuder; Pieter H Reitsma; Mettine H A Bos
Journal:  J Thromb Haemost       Date:  2019-06-17       Impact factor: 5.824

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.